Study of Efficacy and Safety of CRC01 in Adult Large B-cell Lymphoma and B-cell Acute Lymphoblastic Leukemia Patients

Clinical trial NCT04836507 · RECRUITING

Trial details

NCT number: NCT04836507
Sponsor: Curocell Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Relapsed Large B-cell Lymphoma Refractory Large B-cell Lymphoma Diffuse Large B-cell Lymphoma (DLBCL)Primary Mediastinal Large B-Cell Lymphoma (PMBCL)High-grade B-cell Lymphoma Transformed Follicular Lymphoma (TFL)ALL (Acute B-Lymphoblastic Leukemia)

Start date: 2021-03-02
Primary completion: 2030-08-15
Enrollment: 91

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.